HEADER TRANSFERASE 15-NOV-07 2VGO TITLE CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH REVERSINE TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE 12-A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: RESIDUES 78-361; COMPND 5 SYNONYM: AURORA B KINASE, AURORA-B-A, AURORA/IPL1-RELATED KINASE 2-A, COMPND 6 AIRK2-A; COMPND 7 EC: 2.7.11.1; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: INNER CENTROMERE PROTEIN A; COMPND 11 CHAIN: C, D; COMPND 12 FRAGMENT: RESIDUES 797-840; COMPND 13 SYNONYM: MITOTIC PHOSPHOPROTEIN 130, XL-INCENP; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 3 ORGANISM_COMMON: AFRICAN CLAWED FROG; SOURCE 4 ORGANISM_TAXID: 8355; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PGEX; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: XENOPUS LAEVIS; SOURCE 11 ORGANISM_COMMON: AFRICAN CLAWED FROG; SOURCE 12 ORGANISM_TAXID: 8355; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PGEX KEYWDS NUCLEOTIDE-BINDING, SERINE/THREONINE-PROTEIN KINASE, ATP-BINDING, KEYWDS 2 TRANSFERASE, COILED COIL, CELL DIVISION, KINASE, CANCER, INCENP, KEYWDS 3 NUCLEUS, MITOSIS, AURORA B, METAL-BINDING, AMINOTHIAZOLE, KEYWDS 4 PHOSPHORYLATION, MAGNESIUM, CELL CYCLE, CENTROMERE, MICROTUBULE EXPDTA X-RAY DIFFRACTION AUTHOR A.M.D'ALISE,G.AMABILE,M.IOVINO,F.P.DI GIORGIO,M.BARTIROMO,F.SESSA, AUTHOR 2 F.VILLA,A.MUSACCHIO,R.CORTESE REVDAT 5 23-OCT-24 2VGO 1 REMARK REVDAT 4 31-JAN-24 2VGO 1 REMARK REVDAT 3 02-NOV-22 2VGO 1 HETSYN LINK ATOM REVDAT 2 24-FEB-09 2VGO 1 VERSN REVDAT 1 28-OCT-08 2VGO 0 JRNL AUTH A.M.D'ALISE,G.AMABILE,M.IOVINO,F.P.DI GIORGIO,M.BARTIROMO, JRNL AUTH 2 F.SESSA,F.VILLA,A.MUSACCHIO,R.CORTESE JRNL TITL REVERSINE, A NOVEL AURORA KINASES INHIBITOR, INHIBITS COLONY JRNL TITL 2 FORMATION OF HUMAN ACUTE MYELOID LEUKEMIA CELLS. JRNL REF MOL.CANCER THER. V. 7 1140 2008 JRNL REFN ISSN 1535-7163 JRNL PMID 18483302 JRNL DOI 10.1158/1535-7163.MCT-07-2051 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 116.25 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 72884 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3866 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 5157 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE SET COUNT : 279 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5237 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 626 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.72 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.38000 REMARK 3 B22 (A**2) : 2.01000 REMARK 3 B33 (A**2) : -1.69000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.28000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.119 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.114 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.073 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.132 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5484 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7404 ; 1.089 ; 1.987 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 636 ; 4.989 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 264 ;35.450 ;22.727 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 991 ;13.854 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 49 ;16.229 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 758 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4177 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2680 ; 0.191 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3711 ; 0.305 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 515 ; 0.110 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 144 ; 0.167 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 68 ; 0.156 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3278 ; 0.613 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5170 ; 1.016 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2498 ; 1.548 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2234 ; 2.517 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2VGO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 15-NOV-07. REMARK 100 THE DEPOSITION ID IS D_1290034419. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95370 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 72884 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 116.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.25000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 20.20 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2BFX REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.29 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.80000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3970 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 78 REMARK 465 ALA A 79 REMARK 465 LEU A 80 REMARK 465 ALA A 81 REMARK 465 GLU A 82 REMARK 465 MET A 83 REMARK 465 PRO A 84 REMARK 465 LYS A 85 REMARK 465 ARG A 86 REMARK 465 GLN A 356 REMARK 465 SER A 357 REMARK 465 THR A 358 REMARK 465 GLN A 359 REMARK 465 SER A 360 REMARK 465 LYS A 361 REMARK 465 GLU B 132 REMARK 465 GLY B 133 REMARK 465 THR B 358 REMARK 465 GLN B 359 REMARK 465 SER B 360 REMARK 465 LYS B 361 REMARK 465 ASN C 838 REMARK 465 LYS C 839 REMARK 465 SER C 840 REMARK 465 PRO D 797 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 104 -15.97 -141.58 REMARK 500 ASN A 158 -175.90 -176.74 REMARK 500 ASP A 162 -156.53 -127.64 REMARK 500 ASP A 216 44.24 -152.39 REMARK 500 PHE B 104 -11.24 72.00 REMARK 500 ASN B 158 -175.02 -174.73 REMARK 500 ASP B 162 -165.01 -124.26 REMARK 500 ASP B 216 41.30 -149.03 REMARK 500 SER D 803 -91.79 -123.69 REMARK 500 ASN D 838 -163.18 -108.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2063 DISTANCE = 6.45 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AD5 A1357 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AD5 B1359 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2BFX RELATED DB: PDB REMARK 900 MECHANISM OF AURORA-B ACTIVATION BY INCENP AND INHIBITION BY REMARK 900 HESPERADIN. REMARK 900 RELATED ID: 2BFY RELATED DB: PDB REMARK 900 COMPLEX OF AURORA-B WITH INCENP AND HESPERIDIN. REMARK 900 RELATED ID: 2VGP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF AURORA B KINASE IN COMPLEX WITH A REMARK 900 AMINOTHIAZOLE INHIBITOR DBREF 2VGO A 78 361 UNP Q6DE08 AUKBA_XENLA 78 361 DBREF 2VGO B 78 361 UNP Q6DE08 AUKBA_XENLA 78 361 DBREF 2VGO C 797 840 UNP O13024 INCEA_XENLA 797 840 DBREF 2VGO D 797 840 UNP O13024 INCEA_XENLA 797 840 SEQRES 1 A 284 THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR ILE SEQRES 2 A 284 ASP ASP PHE ASP ILE GLY ARG PRO LEU GLY LYS GLY LYS SEQRES 3 A 284 PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN LYS SEQRES 4 A 284 PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN LEU SEQRES 5 A 284 GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU ILE SEQRES 6 A 284 GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG SEQRES 7 A 284 MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR LEU SEQRES 8 A 284 MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS GLU SEQRES 9 A 284 LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER ALA SEQRES 10 A 284 THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR CYS SEQRES 11 A 284 HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO GLU SEQRES 12 A 284 ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE ALA SEQRES 13 A 284 ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG ARG SEQRES 14 A 284 ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO GLU SEQRES 15 A 284 MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP LEU SEQRES 16 A 284 TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY SEQRES 17 A 284 MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR HIS SEQRES 18 A 284 ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO PHE SEQRES 19 A 284 LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU LEU SEQRES 20 A 284 ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY VAL SEQRES 21 A 284 MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG VAL SEQRES 22 A 284 LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS SEQRES 1 B 284 THR ALA LEU ALA GLU MET PRO LYS ARG LYS PHE THR ILE SEQRES 2 B 284 ASP ASP PHE ASP ILE GLY ARG PRO LEU GLY LYS GLY LYS SEQRES 3 B 284 PHE GLY ASN VAL TYR LEU ALA ARG GLU LYS GLN ASN LYS SEQRES 4 B 284 PHE ILE MET ALA LEU LYS VAL LEU PHE LYS SER GLN LEU SEQRES 5 B 284 GLU LYS GLU GLY VAL GLU HIS GLN LEU ARG ARG GLU ILE SEQRES 6 B 284 GLU ILE GLN SER HIS LEU ARG HIS PRO ASN ILE LEU ARG SEQRES 7 B 284 MET TYR ASN TYR PHE HIS ASP ARG LYS ARG ILE TYR LEU SEQRES 8 B 284 MET LEU GLU PHE ALA PRO ARG GLY GLU LEU TYR LYS GLU SEQRES 9 B 284 LEU GLN LYS HIS GLY ARG PHE ASP GLU GLN ARG SER ALA SEQRES 10 B 284 THR PHE MET GLU GLU LEU ALA ASP ALA LEU HIS TYR CYS SEQRES 11 B 284 HIS GLU ARG LYS VAL ILE HIS ARG ASP ILE LYS PRO GLU SEQRES 12 B 284 ASN LEU LEU MET GLY TYR LYS GLY GLU LEU LYS ILE ALA SEQRES 13 B 284 ASP PHE GLY TRP SER VAL HIS ALA PRO SER LEU ARG ARG SEQRES 14 B 284 ARG TPO MET CYS GLY THR LEU ASP TYR LEU PRO PRO GLU SEQRES 15 B 284 MET ILE GLU GLY LYS THR HIS ASP GLU LYS VAL ASP LEU SEQRES 16 B 284 TRP CYS ALA GLY VAL LEU CYS TYR GLU PHE LEU VAL GLY SEQRES 17 B 284 MET PRO PRO PHE ASP SER PRO SER HIS THR GLU THR HIS SEQRES 18 B 284 ARG ARG ILE VAL ASN VAL ASP LEU LYS PHE PRO PRO PHE SEQRES 19 B 284 LEU SER ASP GLY SER LYS ASP LEU ILE SER LYS LEU LEU SEQRES 20 B 284 ARG TYR HIS PRO PRO GLN ARG LEU PRO LEU LYS GLY VAL SEQRES 21 B 284 MET GLU HIS PRO TRP VAL LYS ALA ASN SER ARG ARG VAL SEQRES 22 B 284 LEU PRO PRO VAL TYR GLN SER THR GLN SER LYS SEQRES 1 C 44 PRO ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN SEQRES 2 C 44 ALA ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP SEQRES 3 C 44 ARG MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU SEQRES 4 C 44 LEU PHE ASN LYS SER SEQRES 1 D 44 PRO ILE PRO ALA TRP ALA SER GLY ASN LEU LEU THR GLN SEQRES 2 D 44 ALA ILE ARG GLN GLN TYR TYR LYS PRO ILE ASP VAL ASP SEQRES 3 D 44 ARG MET TYR GLY THR ILE ASP SER PRO LYS LEU GLU GLU SEQRES 4 D 44 LEU PHE ASN LYS SER MODRES 2VGO TPO A 248 THR PHOSPHOTHREONINE MODRES 2VGO TPO B 248 THR PHOSPHOTHREONINE HET TPO A 248 11 HET TPO B 248 11 HET AD5 A1357 29 HET AD5 B1359 29 HETNAM TPO PHOSPHOTHREONINE HETNAM AD5 N~6~-CYCLOHEXYL-N~2~-(4-MORPHOLIN-4-YLPHENYL)-9H- HETNAM 2 AD5 PURINE-2,6-DIAMINE HETSYN TPO PHOSPHONOTHREONINE HETSYN AD5 REVERSINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 5 AD5 2(C21 H27 N7 O) FORMUL 7 HOH *626(H2 O) HELIX 1 1 THR A 89 ASP A 91 5 3 HELIX 2 2 LYS A 126 GLU A 132 1 7 HELIX 3 3 VAL A 134 HIS A 147 1 14 HELIX 4 4 LEU A 178 GLY A 186 1 9 HELIX 5 5 ASP A 189 GLU A 209 1 21 HELIX 6 6 LYS A 218 GLU A 220 5 3 HELIX 7 7 THR A 252 LEU A 256 5 5 HELIX 8 8 PRO A 257 GLU A 262 1 6 HELIX 9 9 LYS A 269 GLY A 285 1 17 HELIX 10 10 SER A 293 ASN A 303 1 11 HELIX 11 11 SER A 313 LEU A 324 1 12 HELIX 12 12 HIS A 327 ARG A 331 5 5 HELIX 13 13 PRO A 333 GLU A 339 1 7 HELIX 14 14 HIS A 340 SER A 347 1 8 HELIX 15 15 THR B 89 ASP B 91 5 3 HELIX 16 16 LYS B 126 GLU B 130 1 5 HELIX 17 17 VAL B 134 SER B 146 1 13 HELIX 18 18 LEU B 178 GLY B 186 1 9 HELIX 19 19 ASP B 189 ARG B 210 1 22 HELIX 20 20 LYS B 218 GLU B 220 5 3 HELIX 21 21 THR B 252 LEU B 256 5 5 HELIX 22 22 PRO B 257 GLU B 262 1 6 HELIX 23 23 LYS B 269 GLY B 285 1 17 HELIX 24 24 SER B 293 ASN B 303 1 11 HELIX 25 25 SER B 313 LEU B 324 1 12 HELIX 26 26 HIS B 327 ARG B 331 5 5 HELIX 27 27 PRO B 333 GLU B 339 1 7 HELIX 28 28 HIS B 340 SER B 347 1 8 HELIX 29 29 PRO C 799 ALA C 802 5 4 HELIX 30 30 SER C 803 LYS C 817 1 15 HELIX 31 31 ASP C 820 TYR C 825 1 6 HELIX 32 32 LYS C 832 PHE C 837 1 6 HELIX 33 33 PRO D 799 SER D 803 5 5 HELIX 34 34 GLY D 804 LYS D 817 1 14 HELIX 35 35 ASP D 820 TYR D 825 1 6 SHEET 1 AA 5 PHE A 93 LYS A 101 0 SHEET 2 AA 5 GLY A 105 GLU A 112 -1 O VAL A 107 N LEU A 99 SHEET 3 AA 5 PHE A 117 PHE A 125 -1 O PHE A 117 N GLU A 112 SHEET 4 AA 5 ARG A 165 LEU A 170 -1 O ILE A 166 N LEU A 124 SHEET 5 AA 5 MET A 156 HIS A 161 -1 N TYR A 157 O MET A 169 SHEET 1 AB 3 GLY A 176 GLU A 177 0 SHEET 2 AB 3 LEU A 222 MET A 224 -1 N MET A 224 O GLY A 176 SHEET 3 AB 3 LEU A 230 ILE A 232 -1 O LYS A 231 N LEU A 223 SHEET 1 AC 2 VAL A 212 ILE A 213 0 SHEET 2 AC 2 VAL A 239 HIS A 240 -1 O VAL A 239 N ILE A 213 SHEET 1 BA 5 PHE B 93 LYS B 101 0 SHEET 2 BA 5 ASN B 106 GLU B 112 -1 O VAL B 107 N LEU B 99 SHEET 3 BA 5 PHE B 117 PHE B 125 -1 O PHE B 117 N GLU B 112 SHEET 4 BA 5 ARG B 165 LEU B 170 -1 O ILE B 166 N LEU B 124 SHEET 5 BA 5 MET B 156 HIS B 161 -1 N TYR B 157 O MET B 169 SHEET 1 BB 3 GLY B 176 GLU B 177 0 SHEET 2 BB 3 LEU B 222 MET B 224 -1 N MET B 224 O GLY B 176 SHEET 3 BB 3 LEU B 230 ILE B 232 -1 O LYS B 231 N LEU B 223 SHEET 1 BC 2 VAL B 212 ILE B 213 0 SHEET 2 BC 2 VAL B 239 HIS B 240 -1 O VAL B 239 N ILE B 213 LINK C ARG A 247 N TPO A 248 1555 1555 1.33 LINK C TPO A 248 N MET A 249 1555 1555 1.33 LINK C ARG B 247 N TPO B 248 1555 1555 1.33 LINK C TPO B 248 N MET B 249 1555 1555 1.33 SITE 1 AC1 9 GLY A 100 ALA A 120 LEU A 154 LEU A 170 SITE 2 AC1 9 GLU A 171 PHE A 172 ALA A 173 GLY A 176 SITE 3 AC1 9 GLU A 177 SITE 1 AC2 10 LYS B 101 VAL B 107 LEU B 154 GLU B 171 SITE 2 AC2 10 PHE B 172 ALA B 173 PRO B 174 GLY B 176 SITE 3 AC2 10 GLU B 177 HOH B2261 CRYST1 45.736 67.600 116.631 90.00 96.59 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021865 0.000000 0.002526 0.00000 SCALE2 0.000000 0.014793 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008631 0.00000